Has Reuel Measom, MD received payments from drug or device companies?

Yes. Drug and device makers reported $49,091 in general payments to Reuel Measom, MD across 197 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reuel Measom, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reuel Measom, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reuel Measom, MD

Interventional Pain Medicine · Albuquerque, NMNPI 1184156630

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Bioventus LLC at 38.2% of the total. Reporting peaked in 2023 at $20,649 and has fallen 57.7% since, to $8,734 in 2025.

$49,091in general payments, 2019–2025

Across 197 payments — averaging $249.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bioventus LLC$19K
Biotronik NRO, Inc.$8K
SPR Therapeutics, Inc$8K
Boston Scientific$3K
Medtronic$3K
Abbott$3K
plus $5K from 16 others

What the payments were for

Consulting fees$4,5509%
Speaking & faculty fees$21,24443%
Grants$5,08810%
Travel & lodging$11,96424%
Food & beverage$5,59611%
Education$6481%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bioventus LLC	31	$18,761
Biotronik NRO, Inc.	11	$8,355
SPR Therapeutics, Inc	22	$7,993
Boston Scientific	8	$3,494
Medtronic	19	$2,870
Abbott	23	$2,814
Relievant Medsystems, Inc.	18	$2,040
Painteq LLC	4	$681
Nevro Corp.	5	$452
Stratus Medical, LLC	1	$350
Nalu Medical, Inc.	10	$283
Stryker	4	$235
Vertos Medical, Inc.	12	$191
Collegium Pharmaceutical, Inc.	12	$147
Saluda Medical Americas, Inc.	7	$140
AbbVie	2	$124
Pfizer	2	$41
Mindray DS USA, Inc.	1	$38
Lundbeck LLC	2	$35
Innovation Technologies Inc	1	$16
Lilly USA, LLC	1	$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$181,459

Medicare patients

282

Services billed

3,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	68	$1,685
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	42	$1,163
Tramadol Hcl	35	$335
Gabapentin	29	$314
Celecoxib	12	$168
Sumatriptan Succinate	12	$142

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Albuquerque

Diego GonzalezAlbuquerque$35K
Athanasios ManoleAlbuquerque$9K
Craig NairnAlbuquerque$4K
Edward PoonAlbuquerque$2K
Kyle SchoenbergerAlbuquerque$2K
Michael MalizzoAlbuquerque$462
Cesar VelardeLas Cruces$3K
Jose RamirezLas Cruces$714

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →